Patterson Companies Inc (PDCO) 30.59 +0.29 (+0.96%)
30.59 +0.29 (+0.96%)
US7033951036 - Common Stock - After market: 30.59 0 (0%)
Patterson Companies Fiscal 2022 Fourth Quarter and Year End Conference Call Scheduled for Wednesday, June 29, 2022
Patterson Companies Declares Regular Quarterly Cash Dividend
7 Stock Picks to Play the Post-Pandemic Return of Dental Visits
The two years away from the “chair” could cynically boost these oral health plays.
Becton Dickinson Stock Near High, Hits 80-Plus RS Rating
Becton Dickinson stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82.
Patterson Companies to Participate in the Piper Sandler Virtual Dental Investor Day
Patterson Companies Declares Regular Quarterly Cash Dividend
Patterson Companies Fiscal 2022 Third-Quarter Conference Call Scheduled for Wednesday, March 2, 2022
Patterson Companies to Present at the 2022 J.P. Morgan Healthcare Conference
Patterson Companies Declares Regular Quarterly Cash Dividend
Patterson Companies Elects Philip McKoy to Board of Directors
Patterson Cos. (PDCO) Moves to Buy: Rationale Behind the Upgrade
Patterson Cos. (PDCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Patterson Companies (PDCO) Beats on Q2 Earnings & Revenues
Patterson Companies' (PDCO) fiscal second-quarter 2022 results benefit from strength in the Animal Health segment.
Patterson Cos. (PDCO) Q2 Earnings and Revenues Surpass Estimates
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 16% and 4.24%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Patterson Companies Reports Fiscal 2022 Second-Quarter Operating Results
What's in Store for Patterson Companies' (PDCO) Q2 Earnings?
Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.